En ung kvinne som mistet kraften i ett bein

Tidsskrift for den Norske Laegeforening

Volumn 131, Issue 6, 2011, Pages 583-586

  Holmøy, Trygve ^a   Braaten, Øivind ^a   Hovden, Inger Anette Hynås ^a   Tallaksen, Chantal M ^b  

^a Nevrologisk avdeling ^*  (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEG; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASE; POINT MUTATION;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; LEG; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASES; POINT MUTATION; SUPEROXIDE DISMUTASE;

EID: 79953150951     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.1499     Document Type: Article

References (14)

1. Bindoff L, Gilhus NE. The genetic basis of muscle disease. Tidsskr Nor Laegeforen 2003; 123: 2588-92.
2. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000; 55: 1262-6.
3. Valdmanis PN, Daoud H, Dion PA et al. Recent advances in the genetics of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 2009; 9: 198-205.
4. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007; 369: 2031-41.
5. Eisen A, Mezei MM, Stewart HG et al. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler 2008; 9: 108-19.
6. Andersen PM, Sims KB, Xin WW et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 62-73.
7. Holmøy T, Bjørgo K, Roos PM. Slowly progressing amyotrophic lateral sclerosis caused by H46R SOD1 mutation. Eur Neurol 2007; 58: 57-8.
8. Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 2009; 10: 769-82.
9. Jonsson PA, Ernhill K, Andersen PM et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 2004; 127: 73-88.
10. Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006; 6: 37-46.
11. Jones CT, Swingler RJ, Simpson SA et al. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-2.
12. Andersen PM, Borasio GD, Dengler R et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. Amyotroph Lateral Scler 2007; 8: 195-213.
13. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585-91.
14. Fanos JH, Gelinas DF, Miller RG. «You have shown me my end»: attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis. Am J Med Genet A 2004; 129A: 248-53.